Role	O
of	O
telomeres	B-Cellular_component
in	O
vascular	B-Multi-tissue_structure
senescence	O
.	O

Telomeres	B-Cellular_component
are	O
DNA	O
regions	O
composed	O
of	O
TTAGGG	O
repeats	O
that	O
are	O
located	O
at	O
the	O
ends	O
of	O
chromosomes	B-Cellular_component
.	O

Specific	O
proteins	O
associate	O
with	O
the	O
telomeres	B-Cellular_component
and	O
form	O
non	O
-	O
nucleosomal	O
DNA	O
-	O
protein	O
complexes	O
that	O
serve	O
as	O
protective	O
caps	O
for	O
the	O
chromosome	B-Cellular_component
ends	O
.	O

There	O
is	O
accumulating	O
evidence	O
that	O
progressive	O
telomere	B-Cellular_component
shortening	O
is	O
closely	O
related	O
to	O
cardiovascular	B-Anatomical_system
disease	O
.	O

For	O
example	O
,	O
vascular	B-Cell
cell	I-Cell
senescence	O
has	O
been	O
reported	O
to	O
occur	O
in	O
human	O
atherosclerotic	B-Pathological_formation
lesions	I-Pathological_formation
and	O
this	O
change	O
is	O
associated	O
with	O
telomere	B-Cellular_component
shortening	O
.	O

Impairment	O
of	O
telomere	B-Cellular_component
integrity	O
causes	O
vascular	B-Multi-tissue_structure
dysfunction	O
,	O
which	O
is	O
prevented	O
by	O
the	O
activation	O
of	O
telomerase	O
.	O

Mice	O
with	O
short	O
telomeres	B-Cellular_component
develop	O
hypertension	O
and	O
exhibit	O
impaired	O
neovascularization	O
.	O

Short	O
telomeres	B-Cellular_component
have	O
also	O
been	O
reported	O
in	O
the	O
leukocytes	B-Cell
of	O
patients	O
with	O
cardiovascular	B-Anatomical_system
disease	O
or	O
various	O
cardiovascular	B-Anatomical_system
risk	O
factors	O
.	O

Although	O
it	O
remains	O
unclear	O
whether	O
short	O
telomeres	B-Cellular_component
directly	O
cause	O
cardiovascular	B-Anatomical_system
disease	O
,	O
manipulation	O
of	O
telomere	B-Cellular_component
function	O
is	O
potentially	O
an	O
attractive	O
strategy	O
for	O
the	O
treatment	O
of	O
vascular	B-Multi-tissue_structure
senescence	O
.	O

